Murray H Rosenthal

Summary

Publications

  1. ncbi Barriers to diagnosis, advances in therapy
    Murray H Rosenthal
    BMR HealthQuest, 3625 Ruffin Rd, Suite 100, San Diego, CA 92123 1841, USA
    J Am Osteopath Assoc 103:S2-9. 2003
  2. ncbi The challenge of comorbid disorders in patients with depression
    Murray H Rosenthal
    BMR HealthQuest, 3625 Ruffin Rd, Suite 100, San Diego, CA 92123 1841, USA
    J Am Osteopath Assoc 103:S10-5. 2003
  3. ncbi Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control
    Murray Rosenthal
    BMR HealthQuest, 3625 Ruffin Road, Suite 100, San Diego, CA 92123, USA
    J Clin Psychiatry 64:1245-9. 2003
  4. ncbi Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study
    Charles DeBattista
    Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, 401 Quarry Road, Room 2137, Stanford, CA 94305, USA
    J Clin Psychiatry 64:1057-64. 2003
  5. ncbi Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
    Murray H Rosenthal
    BMR Healthquest Clinical Trials, San Diego, California 92123, USA
    Clin Neuropharmacol 27:38-43. 2004

Detail Information

Publications5

  1. ncbi Barriers to diagnosis, advances in therapy
    Murray H Rosenthal
    BMR HealthQuest, 3625 Ruffin Rd, Suite 100, San Diego, CA 92123 1841, USA
    J Am Osteopath Assoc 103:S2-9. 2003
    ..These diagnostic and therapeutic options are rapidly becoming available to primary care physicians, who should use them to achieve long-term remission of depressive symptoms...
  2. ncbi The challenge of comorbid disorders in patients with depression
    Murray H Rosenthal
    BMR HealthQuest, 3625 Ruffin Rd, Suite 100, San Diego, CA 92123 1841, USA
    J Am Osteopath Assoc 103:S10-5. 2003
    ....
  3. ncbi Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control
    Murray Rosenthal
    BMR HealthQuest, 3625 Ruffin Road, Suite 100, San Diego, CA 92123, USA
    J Clin Psychiatry 64:1245-9. 2003
    ..Tiagabine, a selective GABA reuptake inhibitor, enhances normal GABA tone. This 10-week, randomized, open-label trial evaluated tiagabine in patients with generalized anxiety disorder (GAD), with paroxetine serving as a positive control...
  4. ncbi Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study
    Charles DeBattista
    Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, 401 Quarry Road, Room 2137, Stanford, CA 94305, USA
    J Clin Psychiatry 64:1057-64. 2003
    ..In this study, we examined the utility of modafinil as an adjunct therapy to treat fatigue and sleepiness in patients with major depression who are partial responders to antidepressants...
  5. ncbi Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia
    Murray H Rosenthal
    BMR Healthquest Clinical Trials, San Diego, California 92123, USA
    Clin Neuropharmacol 27:38-43. 2004
    ..Additional controlled studies are warranted...